Skip to main
ARTV
ARTV logo

ARTV Market Capitalization Overview

Market Cap: $48.24M as of Jun 13, 2025

$48.24M
Past Month-$3.66M (7.04%)
As of Jun 13, 2025, ARTV has a market capitalization of $48.24M. Over the past 30 days, its market cap has decreased by -18.14%, while in the last 12 months, it has decreased by -80.3%.

Market capitalization represents the total value of Artiva Biotherapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

ARTV Market Cap Formula = Stock Price * Shares Outstanding

The market cap of ARTV helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ARTV Market Cap History

DateMarket CapChange
Jun 2, 2025$47.27M-18.14%
May 1, 2025$57.75M-21.00%
Apr 1, 2025$73.09M-23.24%
Mar 3, 2025$95.22M-19.84%
Feb 3, 2025$118.78M-50.95%
Jan 2, 2025$242.17M-21.80%

ARTV End of Year Market Cap History

DateMarket CapChange
2025$48.24M-80.30%
2024$244.84M

FAQs About Artiva Biotherapeutics Inc (ARTV) Market Cap

As of Jun 13, 2025, the market capitalization of ARTV is $48.24M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Artiva Biotherapeutics Inc’s market capitalization has decreased by -7.04%, changing from $51.90M to $48.24M as of Jun 13, 2025.

In the last 3 months, Artiva Biotherapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Artiva Biotherapeutics Inc’s market capitalization increased from – in January to $244.84M in December, reflecting a — change.

Artiva Biotherapeutics Inc (ARTV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.